PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2007 March; 8(1): E63–E69.
Published online 2006 July 19. doi:  10.1208/pt0801009
PMCID: PMC2750444

Preparation and assessment of novel coprocessed superdisintegrant consisting of crospovidone and sodium starch glycolate: A technical note

Summary and Conclusion

Coprocessed superdisintegrant consisting of crospovidone and SSG exhibited good flow and compression characteristics. Cefixime trihydrate and ibuprofen tablets containing coprocessed superdisintegrant exhibited quick disintegration and improved drug dissolution.

Keywords: Crospovidone, sodium starch glycolate, coprocessing, disintegration, dissolution

Full Text

The Full Text of this article is available as a PDF (127K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Martin A. Physical Pharmacy. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001. Drug Product Design; pp. 512–555.
2. Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia, PA: Lea & Febiger; 1986. pp. 293–345.
3. Gohel MC, Jogani PD. A review of co-processed directly compressible excipients. J Pharm Pharm Sci. 2005;8:76–93. [PubMed]
4. Nachegari SK, Bansal AK. Coprocessed excipients for solid dosage forms. Pharm Technol. 2004;28:52–64.
5. Haldar R, Ray DB, Levin M. Screening of most effective superdisintegrant for the development of fast dissolving tablet formulation [abstract]. In:AAPSJ [serial online] vol. Abstract W5221. 2005.
6. He X, Kibbe AH. Crospovidone. In: Rowe RC, Sheskey PJ, Weller PJ, editors. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: London: American Pharmaceutical Association; Pharmaceutical Press; 2003. pp. 184–185.
7. Zhao N, Augsburger LL. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS Pharm Sci Tech. 2005;6:E120–E126. doi: 10.1208/pt060119. [PMC free article] [PubMed] [Cross Ref]
8. Miller RW. Sodium starch glycolate. In: Rowe RC, Sheskey PJ, Weller PJ, editors. Handbook of Pharmaceutical Excipients. 4th ed. Washington, DC: American Pharmaceutical Association; 2003. pp. 581–584.
9. United States Pharmacopeia and National Formulary (USP 29-NF 24). Rockville, MD: US Pharmacopeia; 2006.
10. Rios M. Developments in powder flow testing. Pharm Technol. 2006;30:38–49.
11. Shin SC, Oh IJ, Lee YB, Choi HK, Choi JS. Enhanced dissolution of furosemide by coprecipitating or cogrinding with crospovidone. Int J Pharm. 1998;175:17–24. doi: 10.1016/S0378-5173(98)00260-9. [Cross Ref]
12. Alderborn G, Nystrom C. Pharmaceutical Powder Compaction Technology. New York, NY: Marcel Dekker, Inc; 2007.
13. Zhang Y, Chakrabarti S. Using excipient as binder. Manufacturing Chemist. 2003;74:61–62.
14. Rudnic E. Oral solid dosage forms. In: Gennaro AR, editor. Remington: The Science and Practice of Pharmacy. 19th ed. Easton, PA: Mack Publishing Company; 1995. pp. 1615–1649.
15. Bolhuis GK, Zuurman K, Wierik GHP. Improvement of dissolution of poorly soluble drugs by solid deposition on a superdisintegrant. II. The choice of superdisintegrants and effect of granulation. Eur J Pharm Sci. 1997;5:63–69. doi: 10.1016/S0928-0987(96)00256-4. [Cross Ref]
16. Inactive Ingredient Guide (Redacted). U.S. Food and Drug Administration, Center for Drug Evaluation and Research. January, 1996; Available at: http://www.fda.gov/eder/drug/iig/default.htm. Accessed June 18, 2006.

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists